Previous 10 | Next 10 |
TUCSON, Ariz., Feb. 11, 2020 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics , Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today highlighted the HTG EdgeSeq Mouse mRNA Tumor Response Panel as a way to identify endogenous targets of cardia...
TUCSON, Ariz., Feb. 05, 2020 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics , Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today highlighted the reproducibility of the HTG EdgeSeq miRNA Whole Transcriptome Assay (miRNA WTA), as reported i...
TUCSON, Ariz., Jan. 28, 2020 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics , Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today announced it has received notification of validation of European patent number EP 3356554 for its methods for...
Preliminary full year 2019 unaudited revenue of $19.2 million Cash and cash equivalents of $33.0 million as of December 31, 2019 TUCSON, Ariz., Jan. 13, 2020 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics , Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advan...
TUCSON, Ariz., Dec. 03, 2019 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics , Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today announced that it will host a Key Opinion Leader (KOL) luncheon at 12:00 pm ET on Friday, December 13 th in ...
TUCSON, Ariz., Nov. 19, 2019 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics , Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, yesterday announced the release of its HTG EdgeSeq Reveal data analysis software, version 2.0.0. HTG EdgeSe...
HTG Molecular Diagnostics, Inc. (HTGM) Q3 2019 Earnings Conference Call November 12, 2019, 16:30 ET Company Participants Monique Kosse - LifeSci Advisors John Lubniewski - President, CEO & Director Shaun McMeans - SVP, Finance & Administration, CFO, Secretary and Treasure...
HTG Molecular (NASDAQ: HTGM ): Q3 GAAP EPS of -$0.15 misses by $0.01 . More news on: HTG Molecular Diagnostics, Inc., Earnings news and commentary, Stocks on the move, Healthcare stocks news, , Read more ...
Product and product-related services revenue increased by 228% and 125% in the three and nine-month periods, respectively, compared to the prior year periods Call scheduled for today, November 12, at 4:30pm ET TUCSON, Ariz., Nov. 12, 2019 (GLOBE NEWSWIRE) -- HTG Molecular Diag...
Quick Take Centogene ( OTC:CNTG ) has filed to raise $60 million from the sale of common stock in a U.S. IPO, according to an amended F-1/A registration statement . The company provides genetic insights to researchers and clinicians in various regions worldwide. CNTG is producing accele...
News, Short Squeeze, Breakout and More Instantly...
HTG Molecular Diagnostics Inc. Company Name:
HTGM Stock Symbol:
NASDAQ Market:
HTG Molecular Diagnostics Inc. Website:
TUCSON, Ariz., May 18, 2023 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics , Inc. (Nasdaq: HTGM) (HTG), a platform-based life science tools and drug discovery company, today announced that its management team will present the advantages of its proprietary drug discovery engine at the 2023 Biot...
TUCSON, Ariz., May 16, 2023 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics , Inc. (Nasdaq: HTGM) (HTG), a platform-based life science tools and drug discovery company, today reported achievement of another technical milestone in its drug discovery business. HTG is pioneering a proprietar...
TUCSON, Ariz., May 10, 2023 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics , Inc. (Nasdaq: HTGM) (HTG), a platform-based life science tools and drug discovery company, today reported financial results for the quarter ended March 31, 2023 and provided recent drug discovery business highlig...